(VIANEWS) – AbbVie (ABBV), Nu Skin Enterprises (NUS), Westwood Holdings Group (WHG) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. AbbVie (ABBV)
160.27% Payout Ratio
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Earnings Per Share
As for profitability, AbbVie has a trailing twelve months EPS of $3.66.
PE Ratio
AbbVie has a trailing twelve months price to earnings ratio of 37.87. Meaning, the purchaser of the share is investing $37.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.32%.
Volume
Today’s last reported volume for AbbVie is 1084840 which is 77.11% below its average volume of 4741050.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AbbVie’s EBITDA is 5.3.
2. Nu Skin Enterprises (NUS)
134.05% Payout Ratio
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Earnings Per Share
As for profitability, Nu Skin Enterprises has a trailing twelve months EPS of $1.16.
PE Ratio
Nu Skin Enterprises has a trailing twelve months price to earnings ratio of 15.3. Meaning, the purchaser of the share is investing $15.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.03%.
3. Westwood Holdings Group (WHG)
130.43% Payout Ratio
Westwood Holdings Group, Inc., through its subsidiaries, manages investment assets and provides services for its clients. The company operates in two segments, Advisory and Trust. The Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals, and the Westwood Funds; and investment sub-advisory services to mutual funds, pooled investment vehicles, and its Trust segment. The Trust segment offers trust and custodial services; and participates in common trust funds that it sponsors to institutions and high net worth individuals. Westwood Holdings Group, Inc. was founded in 1983 and is based in Dallas, Texas.
Earnings Per Share
As for profitability, Westwood Holdings Group has a trailing twelve months EPS of $0.46.
PE Ratio
Westwood Holdings Group has a trailing twelve months price to earnings ratio of 23.7. Meaning, the purchaser of the share is investing $23.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.17%.
Yearly Top and Bottom Value
Westwood Holdings Group’s stock is valued at $10.90 at 16:23 EST, way under its 52-week high of $14.20 and way above its 52-week low of $8.91.
Moving Average
Westwood Holdings Group’s value is way above its 50-day moving average of $9.89 and below its 200-day moving average of $11.33.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Westwood Holdings Group’s EBITDA is 0.64.
4. Eaton Vance Corporation Eaton Vance Tax (ETW)
69.65% Payout Ratio
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. It is co-managed by Parametric Portfolio Associates LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund also writes call options on one or more U.S. and foreign indices on a substantial portion of the value of its common stock portfolio. It benchmarks the performance of its portfolio against the S&P 500 Index, the CBOE S&P 500 BuyWrite Index, the CBOE NASDAQ-100 BuyWrite Index, and the FTSE Eurotop 100 Index. Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund was formed on September 30, 2005 and is domiciled in the United States.
Earnings Per Share
As for profitability, Eaton Vance Corporation Eaton Vance Tax has a trailing twelve months EPS of $1.09.
PE Ratio
Eaton Vance Corporation Eaton Vance Tax has a trailing twelve months price to earnings ratio of 6.95. Meaning, the purchaser of the share is investing $6.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.32%.
Moving Average
Eaton Vance Corporation Eaton Vance Tax’s worth is above its 50-day moving average of $7.53 and below its 200-day moving average of $7.95.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.1%, now sitting on 21.99M for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 20, 2023, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 9.37%.
Volume
Today’s last reported volume for Eaton Vance Corporation Eaton Vance Tax is 368863 which is 0.47% above its average volume of 367120.
5. ATN International (ATNI)
68.69% Payout Ratio
ATN International, Inc., through its subsidiaries, provides telecommunications services. It operates in three segments: International Telecom, US Telecom, and Renewable Energy. The International Telecom segment provides fixed data and voice; fixed, carrier, managed, and mobility services to customers in Bermuda, the Cayman Islands, Guyana, and the US Virgin Islands, as well as video services in Bermuda, the Cayman Islands, and the US Virgin Islands. This segment also offers mobile, data, and voice services to retail and business customers in Bermuda, Guyana, and US Virgin Islands under the One, GTT+, and Viya brands; roaming services; and handsets and accessories. The US Telecom segment provides carrier services, such as wholesale roaming services; fixed, mobility, carrier, and managed services to business and consumer; private network services to enterprise and consumer customers; and site maintenance services and international long-distance services, as well as leases critical network infrastructure, including towers and transport facilities. The Renewable Energy segment provides distributed generation solar power to commercial and industrial customers in India. As of December 31, 2021, it operated seven retail stores in the US Telecom segment and twenty-one retail stores in the International Telecom segment. The company was formerly known as Atlantic Tele-Network, Inc. and changed its name to ATN International, Inc. in June 2016. ATN International, Inc. was incorporated in 1987 and is headquartered in Beverly, Massachusetts.
Earnings Per Share
As for profitability, ATN International has a trailing twelve months EPS of $-0.98.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.87%.
Yearly Top and Bottom Value
ATN International’s stock is valued at $30.99 at 16:23 EST, way below its 52-week high of $50.27 and way higher than its 52-week low of $27.53.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 755.27M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 44.4% and 83.8%, respectively.
6. Bank of South Carolina Corp. (BKSC)
58.62% Payout Ratio
Bank of South Carolina Corporation operates as a bank holding company for The Bank of South Carolina that provides a range of financial products and services primarily in Charleston, Berkeley, and Dorchester counties of South Carolina. Its deposits include non-interest-bearing demand accounts, NOW accounts, money market accounts, time deposits, and savings accounts, as well as certificates of deposit. The company offers secured and unsecured commercial loans, commercial real estate construction loans, consumer construction loans, home equity lines of credit, and mortgage originations, as well as paycheck protection program loans. It operates five banking house locations. The company was founded in 1986 and is headquartered in Charleston, South Carolina.
Earnings Per Share
As for profitability, Bank of South Carolina Corp. has a trailing twelve months EPS of $1.16.
PE Ratio
Bank of South Carolina Corp. has a trailing twelve months price to earnings ratio of 10.69. Meaning, the purchaser of the share is investing $10.69 for every dollar of annual earnings.
Moving Average
Bank of South Carolina Corp.’s value is way higher than its 50-day moving average of $11.13 and below its 200-day moving average of $13.69.
Yearly Top and Bottom Value
Bank of South Carolina Corp.’s stock is valued at $12.40 at 16:23 EST, way under its 52-week high of $17.58 and way above its 52-week low of $9.52.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Sales Growth
1’s sales growth is 1% for the ongoing quarter and 1% for the next.
